BioMagnetic Solutions Seeks to Revolutionize Cancer Diagnosis & Treatment with New Generation of Magnetic Cell Separation Technology
Paul Liberti, who founded BioMagnetic Solutions in 2011, is no stranger to the life sciences. A trailblazer in magnetic cell separation, Liberti now seeks to cultivate cutting-edge ferrofluid technology that could revolutionize the diagnosis and treatment of cancer.
In the 1980s, Liberti became a pioneer in the world of magnetic cell sorting with the invention of novel magnetic nanoparticles. Upon this invention, he founded Immunicon. The company’s early discoveries garnered enthusiasm in the research community; the technology, branded CellSearch, was acquired by the pharmaceutical company Johnson & Johnson. J&J eventually abandoned development of the technology.
Today, Liberti has rebooted this venture. “In my previous career, we were doing the applications, but we didn’t realize there were better ways to do what we were doing,” he said.